Wong, W Wei-Lynn;Vince, James E;Lalaoui, Najoua;Lawlor, Kate E;Chau, Diep;Bankovacki, Aleksandra;Anderton, Holly;Metcalf, Donald;O'Reilly, Lorraine;Jost, Philipp J;Murphy, James M;Alexander, Warren S;Strasser, Andreas;Vaux, David L;Silke, John.cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner..Blood.2014.123.16.2562-72

Borchmann, Peter;Goergen, Helen;Kobe, Carsten;Lohri, Andreas;Greil, Richard;Eichenauer, Dennis A;Zijlstra, Josée M;Markova, Jana;Meissner, Julia;Feuring-Buske, Michaela;Hüttmann, Andreas;Dierlamm, Judith;Soekler, Martin;Beck, Hans-Joachim;Willenbacher, Wolfgang;Ludwig, Wolf-Dieter;Pabst, Thomas;Topp, Max S;Hitz, Felicitas;Bentz, Martin;Keller, Ulrich Bernd;Kühnhardt, Dagmar;Ostermann, Helmut;Schmitz, Norbert;Hertenstein, Bernd;Aulitzky, Walter;Maschmeyer, Georg;Vieler, Tom;Eich, Hans;Baues, Christian;Stein, Harald;Fuchs, Michael;Kuhnert, Georg;Diehl, Volker;Dietlein, Markus;Engert, Andreas.PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group..Lancet.2018.390.10114.2790-2802

Kurup, Sonali;McAllister, Bradley;Liskova, Pavlina;Mistry, Trusha;Fanizza, Anthony;Stanford, Dan;Slawska, Jolanta;Keller, Ulrich;Hoellein, Alexander.Design, synthesis and biological activity of N-phenylsubstituted-7H-pyrrolo[2,3-d]pyrimidin-4-amines as dual inhibitors of aurora kinase A and epidermal growth factor receptor kinase..J Enzyme Inhib Med Chem.2018.33.1.74-84

Bailey, D L;Pichler, B J;Gückel, B;Antoch, G;Barthel, H;Bhujwalla, Z M;Biskup, S;Biswal, S;Bitzer, M;Boellaard, R;Braren, R F;Brendle, C;Brindle, K;Chiti, A;la Fougère, C;Gillies, R;Goh, V;Goyen, M;Hacker, M;Heukamp, L;Knudsen, G M;Krackhardt, A M;Law, I;Morris, J C;Nikolaou, K;Nuyts, J;Ordonez, A A;Pantel, K;Quick, H H;Riklund, K;Sabri, O;Sattler, B;Troost, E G C;Zaiss, M;Zender, L;Beyer, Thomas.Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany..Mol Imaging Biol.2018.20.1.4-20

Krackhardt, Angela M;Heinrich, Bernhard.[Progress in cancer immunotherapy]..MMW Fortschr Med.2017.159.14.48-53

Audehm, Stefan;Krackhardt, Angela M.Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation..Oncol Res Treat.2017.40.11.691-696

Knop, S;Langer, C;Engelhardt, M;Mügge, L-O;Reichle, A;Rösler, W;Bassermann, F;Hertenstein, B;Kunitz, A;Röllig, C;Ostermann, H;Schäfer-Eckart, K;Ringhoffer, M;Günther, A;Junghanss, C;Biersack, H;Schreder, M;Liebert, A;Held, S;Einsele, H;Bargou, R C.Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma..Leukemia.2017.31.8.1816-1819

Einsele, H;Knop, S;Vogel, M;Müller, J;Kropff, M;Metzner, B;Langer, C;Sayer, H;Jung, W;Dürk, H A;Salwender, H;Wandt, H;Bassermann, F;Gramatzki, M;Rösler, W;Wolf, H-H;Brugger, W;Engelhardt, M;Fischer, T;Liebisch, P;Straka, C.Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma..Leukemia.2017.31.6.1463-1466

Krönke, J;Kuchenbauer, F;Kull, M;Teleanu, V;Bullinger, L;Bunjes, D;Greiner, A;Kolmus, S;Köpff, S;Schreder, M;Mügge, L-O;Straka, C;Engelhardt, M;Döhner, H;Einsele, H;Bassermann, F;Bargou, R;Knop, S;Langer, C.IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)..Leukemia.2017.31.6.1363-1367

Schottelius, Margret;Osl, Theresa;Poschenrieder, Andreas;Hoffmann, Frauke;Beykan, Seval;Hänscheid, Heribert;Schirbel, Andreas;Buck, Andreas K;Kropf, Saskia;Schwaiger, Markus;Keller, Ulrich;Lassmann, Michael;Wester, Hans-Jürgen.[Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent..Theranostics.2017.7.9.2350-2362